Education
About Us
Working with TipRanks
Follow Us
Privia Health Group (PRVA)
NASDAQ:PRVA
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.05Last Year’s EPS
0.03Same Quarter Last Year
Strong Buy
Based on 17 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -1.97%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
Privia Health demonstrated strong growth and financial performance, with significant increases in provider signings, practice collections, and EBITDA. The strategic entry into the Arizona market and increased guidance for 2025 further highlight the company's positive trajectory. However, challenges in the Medicare Advantage space and potential headwinds in value-based care present areas of concern.Company Guidance
In the first quarter of 2025, Privia Health reported strong financial performance and raised its full-year outlook as a result of robust operating execution and growth across its markets. The company achieved an 11.7% increase in implemented provider growth and an 11.1% rise in value-based attribution, contributing to a 12.8% growth in total practice collections. Adjusted EBITDA surged by 35.1%, with the EBITDA margin expanding by 460 basis points year-over-year. Privia Health's strategic entry into Arizona, through a $95 million partnership with IMS, is expected to be EBITDA positive by the fourth quarter of 2025 and make a meaningful contribution to adjusted EBITDA in 2026. The company now operates across 15 states and the District of Columbia, serving 1.27 million attributed lives, with a diversified mix of commercial and government value-based care programs. As a result of this strong start, Privia Health has raised its 2025 guidance to the mid to high end of its initial range, while maintaining its guidance for attributed lives.Strong Growth in Provider Signings and Practice Collections
Implemented Provider growth of 11.7% year-over-year and Practice Collections growth of 12.8% to $798.6 million.
Significant EBITDA Increase
Adjusted EBITDA increased by 35.1% year-over-year, with EBITDA margin expanding 460 basis points.
Strategic Entry into Arizona Market
Partnership with IMS, one of the largest independent multi-specialty practices, with 70 providers and 28,000 attributed lives, valued at $95 million.
Increased 2025 Guidance
Raised full-year 2025 guidance due to strong first-quarter performance and visibility throughout the remainder of the year.
Healthy Balance Sheet
Ended the first quarter with $469 million in cash and no debt, providing significant financial flexibility.
PRVA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRVA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $23.32 | $25.07 | +7.50% |
Feb 27, 2025 | $24.06 | $25.46 | +5.82% |
Nov 07, 2024 | $21.16 | $22.53 | +6.47% |
Aug 08, 2024 | $18.27 | $19.35 | +5.91% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Privia Health Group (PRVA) report earnings?
Privia Health Group (PRVA) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Privia Health Group (PRVA) earnings time?
Privia Health Group (PRVA) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRVA EPS forecast?
PRVA EPS forecast for the fiscal quarter 2025 (Q2) is 0.05.